Neuralstem

NEURALSTEM IS A biotherapeutics company with corporate headquarters in Rockville, Maryland. The corporate mission of Neuralstem is to apply stem cell research to the treatment of diseases of the central nervous system (CNS) including ischémie paraplegia, traumatic spinal cord injury, amyotrophic lateral sclerosis (ALS, aka Lou Geh—rig's disease), and Parkinson's disease. Treatment is promoted with Neuralstem's patented human neural stem cell technology.

Neuralstem's stock is publicly traded on the American Stock Exchange (AmexR) under the ticker symbol CUR; previously, Neuralstem was traded over the counter under the symbol NLRS. Karl Johe (Ph.D.), Richard Garr (J.D.), and Merrill Solomon founded the company in 1996. Dr. Johe is the scientific founder and current chairman of the board of directors of the company. Prior to creating the company, he ...